1. Who benefits from portal vein resection during pancreaticoduodenectomy for pancreatic cancer?
- Author
-
Launois B, Stasik C, Bardaxoglou E, Meunier B, Campion JP, Greco L, and Sutherland F
- Subjects
- Adenocarcinoma mortality, Female, Humans, Male, Middle Aged, Pancreatic Neoplasms mortality, Retrospective Studies, Survival Analysis, Treatment Outcome, Adenocarcinoma surgery, Pancreatic Neoplasms surgery, Pancreaticoduodenectomy, Portal Vein surgery
- Abstract
Portal vein resection during pancreaticoduodenectomy has recently experienced renewed interest. We describe our results with this procedure over a 20-year period. Among 88 consecutive pancreatectomies for cancer of head of the pancreas, 14 included en bloc removal of the portal vein. There was no hospital mortality. Only 21% were found to have histologically confirmed cancer invasion, and the remainder had inflammatory adherence. Two-year survival was 15% compared to 34% for patients who did not have portal vein resection. There were no 5-year survivors. We discuss our results in light of other recent reports.
- Published
- 1999
- Full Text
- View/download PDF